abstract |
(57) Abstract: Formula (I) wherein, for example, A is a sulfonyl group or an acyl group, B is N or CH, M contains a ring, and K and Q are linking groups. ], A method of using such a prostaglandin agonist, a pharmaceutical composition containing such a prostaglandin agonist, and a kit useful for treating bone tissue disorders including osteoporosis. |